Abstract
microRNA (miRNA) is a small non-coding RNA molecule that plays a role in the post-transcriptional regulation of gene expression. Recent evidence shows that miRNAs are involved in various diseases,including neurodegenerative diseases (NDs) such as: Parkinson's disease,Alzheimer's disease,Huntington's disease,Amyotrophic lateral sclerosisand multiple system atrophy (MSA). The initiation and progression of NDs is generally considered to be induced by oxidative stress arising from an imbalance of oxidants and antioxidants. One of the most important antioxidants against oxidative stress is glutathione (GSH),which is a tripeptide composed of cysteine,glutamate and glycine. Among these precursor amino acids,cysteine is the determinant of neuronal GSH synthesis. Cysteine uptake in the neurons is mostly mediated by excitatory amino acid carrier 1 (EAAC1),a member of the sodium-dependent excitatory amino acid transporters. Interestingly,it has been reported that one miRNA,miR-96-5p,regulates the neuroprotective effect of GSH by directly regulating EAAC1 expression. Furthermore,the expressions of miR-96-5p and its target EAAC1 are specifically deregulated in the brains of patients with MSA,suggesting that deregulated miR-96-5p induces MSA via EAAC1 down-regulation. Since miR-96-5p regulation of EAAC1 expression and GSH level is indicated to be under circadian control,a greater understanding of rhythmic miRNA regulation could lead to the use of miRNA in chronotherapy for ND. In this review,we focus on the role of miRNA in the mechanism of GSH synthesis and metabolism; particularly with respect to a critical transport system of its rate-limiting substrate via EAAC1,as well as on the implications and chronotherapeutic potential of miRNA for NDs.
Highlights
AIMS Molecular ScienceReceived date February 2015, Accepted date 9 April 2015, Published date 20 April 2015
MicroRNAs, which were discovered in Caenorhabditis elegans in 1993, are a new class of RNA molecules with roles in the post-transcriptional modulation of gene expression [1]
Several miRNAs have been reported to be involved in the regulation of GSH synthesis and metabolism in various cell lines and tissues
Summary
Received date February 2015, Accepted date 9 April 2015, Published date 20 April 2015. One of the most important antioxidants against oxidative stress is glutathione (GSH), which is a tripeptide composed of cysteine, glutamate and glycine. Among these precursor amino acids, cysteine is the determinant of neuronal GSH synthesis. It has been reported that one miRNA, miR-96-5p, regulates the neuroprotective effect of GSH by directly regulating EAAC1 expression. We focus on the role of miRNA in the mechanism of GSH synthesis and metabolism; with respect to a critical transport system of its rate-limiting substrate via EAAC1, as well as on the implications and chronotherapeutic potential of miRNA for NDs
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
